A Future Of Medicine

Heme Review

May 04, 2020•33 min•Season 1Ep. 4

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Support this podcast! https://anchor.fm/chubbyemu/support

Video version of this video: https://youtu.be/iVt5BpoTHYg

Tweet me: https://twitter.com/HemeReview

IG me: https://instagram.com/HemeReview

Music by Lifeformed: http://lifeformed.bandcamp.com/

References:

[0] Chapman PB et. al. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.Ann Oncol. 2017 Oct 1;28(10):2581-2587. https://www.ncbi.nlm.nih.gov/pubmed/28961848

[1] Chapman PB. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 2011; 364:2507-2516. https://www.nejm.org/doi/full/10.1056/NEJMoa1103782

[2] Amy Harmon. New Drugs Stir Debate on Rules of Clinical Trials. New York Times, September 19, 2010. https://www.nytimes.com/2010/09/19/health/research/19trial.html

For the best experience, listen in Metacast app for iOS or Android